Skip to main content

Peer Review reports

From: Clinical characteristics of hyperprogressive disease in NSCLC after treatment with immune checkpoint inhibitor: a systematic review and meta-analysis

Original Submission
25 Feb 2020 Submitted Original manuscript
24 Mar 2020 Reviewed Reviewer Report - Jianchun Duan
11 Apr 2020 Reviewed Reviewer Report - Stefano Vagge
27 May 2020 Reviewed Reviewer Report - Roland Bassett
25 Jun 2020 Author responded Author comments - Yan Chen
Resubmission - Version 2
25 Jun 2020 Submitted Manuscript version 2
2 Jul 2020 Author responded Author comments - Yan Chen
Resubmission - Version 3
2 Jul 2020 Submitted Manuscript version 3
Publishing
23 Jul 2020 Editorially accepted
29 Jul 2020 Article published 10.1186/s12885-020-07206-4

You can find further information about peer review here.

Back to article page